Absolutely. Same point for $AMRN as for $NVS Entresto. By using the “wrong” comparitor, they generate positive data but leave unanswered questionshttps://twitter.com/Adrian_H/status/1062473481860931584 …
I'm also interested in the cost-effectiveness, based on the cost of Vascepa and the NNT (21 events prevented/5 patient-years) it looks like ~$315,000 per averted event even if the mineral oil didn't skew the results
-
-
63,000 per event prevented.
-
How so? By my calculations, based on a 5-year NNT of 21, and a monthly cost of $250 (averaged from a few online stores) for the 4g daily dose cited in the study, it would be 12*250*5*21 = $315,000 My cost for Vascepa could, of course, be incorrect, is it cheaper?
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.